Child evangelism among juniors in Brazil

https://place.asburyseminary.edu/ecommonsatsdissertations/2381/thumbnail.jp

Mineralogical characterization of scalings formed in geothermal sites in the Upper Rhine Graben before and after the application of sulfate inhibitors

Scale formation processes in the surface installations of geothermal power plants may have a negative effect on power plant performance. In addition, scales formed within the geothermal water circuit frequently accumulate natural radionuclides. Consequently, scale formation may lead to radiation dose rates, which are of radiological concern, and deposits, which may have to be disposed as radioactive waste. In order to minimize these problems and to foster geothermal power plant availability, it is of major interest to understand scale formation processes and to develop methods for their inhibition. One important pre-requisite towards this goal is a sound mineralogical and geochemical characterization of the formed material. Geothermal brines at sites in the Upper Rhine Graben are in general highly mineralized and become, upon cooling in the heat exchanger, supersaturated with respect to sulfate solid-solutions, e.g. (Ba,Sr)SO4, and other mineral phases. Some geothermal power plants very successfully tested the application of sulfate scaling inhibitors. Here we present mineralogical analyses of scale samples from geothermal power plants in the Upper Rhine Valley deposited in absence and presence of sulfate scaling inhibitors. Solid samples are investigated using wet-chemistry (after digestion), XRPD, SEM-EDX, XPS, EA-IRMS, Raman spectroscopy, and XANES (for explanation of abbreviations, see main text). Samples of scales deposited in the absence of a sulfate scaling inhibitor mainly consist of two phases. The largest part is made up of a barite type (Ba,Sr,Ca)SO4 solid-solution. Traces of Ra occurring in the scaling are assumed to be incorporated in the barite type solid solution. Further minor phases are sulfide phases, either an Xray amorphous nano-particulate phase or galena (PbS). Since the application of the sulfate inhibitor, sulfate minerals are no longer detectable in the scale samples. Subsequent scalings are Pb-dominated and consist mainly of galena (PbS), elemental lead (Pb), arsenic (As) and antimony (Sb). As and Sb are likely present as a nanocrystalline intermetallic mixed compound ((Sb, As) or Pb3(Sb,As)2S3). The absence of barite-type minerals demonstrates the success of the application of the sulfate inhibitor. The precipitation of elemental Pb, As, and Sb, which are more noble than iron, may enhance the corrosion of mild steel pipes in the geothermal water circuit. Elution tests and oxidation of the scalings upon storage at atmospheric conditions demonstrate that proper disposal of the toxic heavy metal and metalloid containing scalings may be challenging

Local and systemic therapy of recurrent medulloblastomas in children and adolescents: results of the P-HIT-REZ 2005 study

SIMPLE SUMMARY: A medulloblastoma recurrence is usually associated with an unfavorable prognosis. The German P-HIT-REZ 2005 Study gathered data from patients with relapsed medulloblastomas treated in different, non-randomized therapy arms dependent on preconditions of the patients (previous treatment, comorbidities, relapse pattern), the decision of treating physicians, and the patients’/parents’ choice. A total of 93 evaluable patients with refractory or relapsed medulloblastoma were enrolled. The main aim of this study was to analyze the impact of patient and disease characteristics as well as local and systemic therapies on post-relapse progression-free (PFS) and overall survival (OS). In multivariate analysis, a short time until the first recurrence (<18 months) was the strongest predictor for a worse PFS and OS, which was mainly associated with molecular subgroup 3. Metastatic disease, at relapse, only had a significant impact on OS. Re-biopsy, at relapse, is highly recommended to investigate the histopathological and molecular genetic tumor characteristics and to exclude a secondary malignancy. ABSTRACT: Recurrent medulloblastomas are associated with survival rates <10%. Adequate multimodal therapy is being discussed as having a major impact on survival. In this study, 93 patients with recurrent medulloblastoma treated in the German P-HIT-REZ 2005 Study were analyzed for survival (PFS, OS) dependent on patient, disease, and treatment characteristics. The median age at the first recurrence was 10.1 years (IQR: 6.9–16.1). Median PFS and OS, at first recurrence, were 7.9 months (CI: 5.7–10.0) and 18.5 months (CI: 13.6–23.5), respectively. Early relapses/progressions (<18 months, n = 30/93) found mainly in molecular subgroup 3 were associated with markedly worse median PFS (HR: 2.34) and OS (HR: 3.26) in regression analyses. A significant survival advantage was found for the use of volume-reducing surgery as well as radiotherapy. Intravenous chemotherapy with carboplatin and etoposide (ivCHT, n = 28/93) showed improved PFS and OS data and the best objective response rate (ORR) was 66.7% compared to oral temozolomide (oCHT, n = 47/93) which was 34.8%. Intraventricular (n = 43) as well as high-dose chemotherapy (n = 17) at first relapse was not related to a significant survival benefit. Although the results are limited due to a non-randomized study design, they may serve as a basis for future treatment decisions in order to improve the patients’ survival

Glycan-dependent binding of galectin-1 to neuropilin-1 promotes axonal regeneration after spinal cord injury

Following spinal cord injury (SCI), semaphorin 3A (Sema3A) prevents axonal regeneration through binding to the neuropilin-1 (NRP-1)/PlexinA4 receptor complex. Here, we show that galectin-1 (Gal-1), an endogenous glycan-binding protein, selectively bound to the NRP-1/PlexinA4 receptor complex in injured neurons through a glycan-dependent mechanism, interrupts the Sema3A pathway and contributes to axonal regeneration and locomotor recovery after SCI. Although both Gal-1 and its monomeric variant contribute to de-activation of microglia, only high concentrations of wild-type Gal-1 (which co-exists in a monomer-dimer equilibrium) bind to the NRP-1/PlexinA4 receptor complex and promote axonal regeneration. Our results show that Gal-1, mainly in its dimeric form, promotes functional recovery of spinal lesions by interfering with inhibitory signals triggered by Sema3A binding to NRP-1/PlexinA4 complex, supporting the use of this lectin for the treatment of SCI patients.Fil: Quintá, Héctor Ramiro. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Fisicoquímica Biológicas; ArgentinaFil: Pasquini, Juana Maria. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Fisicoquímica Biológicas; ArgentinaFil: Rabinovich, Gabriel Adrian. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; ArgentinaFil: Pasquini, Laura Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Fisicoquímica Biológicas; Argentin

Genetic Studies of Leptin Concentrations Implicate Leptin in the Regulation of Early Adiposity.

Leptin influences food intake by informing the brain about the status of body fat stores. Rare LEP mutations associated with congenital leptin deficiency cause severe early-onset obesity that can be mitigated by administering leptin. However, the role of genetic regulation of leptin in polygenic obesity remains poorly understood. We performed an exome-based analysis in up to 57,232 individuals of diverse ancestries to identify genetic variants that influence adiposity-adjusted leptin concentrations. We identify five novel variants, including four missense variants, in LEP, ZNF800, KLHL31, and ACTL9, and one intergenic variant near KLF14. The missense variant Val94Met (rs17151919) in LEP was common in individuals of African ancestry only, and its association with lower leptin concentrations was specific to this ancestry (P = 2 × 10-16, n = 3,901). Using in vitro analyses, we show that the Met94 allele decreases leptin secretion. We also show that the Met94 allele is associated with higher BMI in young African-ancestry children but not in adults, suggesting that leptin regulates early adiposity

Survey Results of the Oregon Connecting to Collections Planning Project

OregonInstitute of Museum and Library Service